Cardiac Findings and Events Observed in an Open-Label Clinical Trial of Tafamidis in Patients With Non-Val30Met and Non-Val122Ile Hereditary Transthyretin Amyloidosis
Journal of Cardiovascular Translational Research - United States
doi 10.1007/s12265-015-9613-9
Full Text
Open PDFAbstract
Available in full text
Date
March 1, 2015
Authors
Publisher
Springer Science and Business Media LLC